Form 4: Celcuity Inc. Executive Acquires Stock Options

Lance G. Laing, Chief Science Officer of Celcuity Inc., reports the acquisition of stock options.

Summary

• On February 13, 2025, Lance G. Laing, the Chief Science Officer of Celcuity Inc., acquired 10,962 stock options with an exercise price of $12.62.
• These options vest in full on February 21, 2025, and expire on February 13, 2035.
• Laing also granted power of attorney to Griffin D. Foster, Jonathan R. Zimmerman, Sheremy R. Anderson, and Amra Hoso to handle SEC filings related to company securities.

Sentiment

Score: 5

Explanation: The document is a routine regulatory filing, so the sentiment is neutral. It simply reports a transaction.

Positives

• The acquisition of stock options by a key executive could be seen as a positive sign, indicating confidence in the company's future performance.

Future Outlook

There are no specific forward-looking statements in this document.

Industry Context

This is a standard SEC Form 4 filing, which is common for publicly traded companies when insiders (officers, directors, or those holding more than 10% of the company's shares) have transactions in the company's stock. It provides transparency to the market about insider activity.

Comparison to Industry Standards

• Form 4 filings are a standard practice across all publicly listed companies in the US, ensuring transparency regarding insider transactions.
• The details provided in this filing are consistent with the information required by the SEC for reporting changes in beneficial ownership.

Stakeholder Impact

• The acquisition of stock options by a key executive could have a minor positive impact on shareholder sentiment.

Key Dates

Keywords

stock options, Form 4, Celcuity Inc., insider trading, Lance G. Laing, securities, acquisition, power of attorney